India Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

What is covered in the report about the “India Drug Delivery Devices Market”?

GlobalData’s “India Drug Delivery Devices Market Outlook to 2023” report is a comprehensive databook report, covering key market data on the India Drug Delivery Devices market. The databook report provides value (USD) and volume (units) within market segments – Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices.

The India Drug Delivery Devices Market report provides key information and data on

  • Annualized market revenues (USD) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company share and distribution share data for Drug Delivery Devices market.
  • Global corporate-level profiles of key companies operating within the India Drug Delivery Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

India Drug Delivery Devices is segmented as follows:

  • Central Venous Catheters
  • Infusion Systems
  • Needle Free Injections
  • Metered Dose Inhaler Devices t

Key Reasons to Purchase

The India Drug Delivery Devices Market report helps you to develop

  • Business strategies by identifying the key market categories poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “India Drug Delivery Devices Market Outlook to 2023” report

  • GlaxoSmithKline Plc
  • AstraZeneca Plc
  • Hospira Inc
  • Becton Dickinson and Co
  • Boehringer Ingelheim GmbH

The GlobalData Differentiation

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

The data and analysis within this report are driven by GlobalData Medical Equipment (GDME) databases. GlobalData Medical Equipment database gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

  • 15,000+ data tables showing market size across more than 780 medical equipment segments and 15 countries, from 2009 and forecast to 2023
  • 10,000+ primary interviews, conducted annually to ensure data and report quality
  • Approximately 4,000+ medical equipment conference reports, industry-leading analysis reports covering growing sectors, market trends, investment opportunities and competitive landscape
  • 600+ medical equipment trends and issues, and investment and M&A trends
  • 56,000+ medical equipment company profiles
  • 4,300+ company profiles of medical equipment manufacturers in China and India
  • 2,000+ company profiles of medical equipment manufacturers in Japan
  • 825+ companies’ revenue splits and market shares
  • 1,900+ quarterly and annual medical equipment company financials
  • 940+ medical equipment company SWOTs
  • 21,500+ pipeline product profiles
  • 34,500+ marketed product profiles
  • 36,000+ clinical trials
  • 36,500+ trial investigators
  • 20,600+ product patents
  • 3,700+ reports on companies with products in development
  • 21,500+ reports on deals in the medical equipment industry
  • 1,300+ surgical and diagnostic procedures by therapy area
  • 50+ key healthcare indicators by country

For more information or to receive a free demonstration of the service, please visit:

http://globaldata.com/medical/Home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

NA

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 7

2 Introduction 8

2 ...

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 7

2 Introduction 8

2.1 What Is This Report About? 8

2.2 Drug Delivery Devices Market Segmentation 8

2.3 Definitions of Markets Covered in the Report 9

3 Drug Delivery Devices Market, India 12

3.1 Drug Delivery Devices Market, India, Revenue ($m), 2009-2023 12

3.2 Drug Delivery Devices Market, India, Revenue Mix ($m), 2016 14

3.3 Drug Delivery Devices Market, India, Category Contribution by Revenue ($m), 2016 15

3.4 Drug Delivery Devices Market, India, Category Comparison by Revenue ($m), 2009-2023 16

3.5 Drug Delivery Devices Market, India, Revenue ($m), 2009-2016 17

3.6 Drug Delivery Devices Market, India, Revenue ($m), 2016-2023 19

3.7 Drug Delivery Devices Market, India, Volume (Units), 2009-2023 21

3.8 Drug Delivery Devices Market, India, Volume (Units), 2009-2016 23

3.9 Drug Delivery Devices Market, India, Volume (Units), 2016-2023 25

3.10 Drug Delivery Devices Market, India, Company Share by Revenue ($m), 2016 27

4 Central Venous Catheters Market, India 29

4.1 Central Venous Catheters Market, India, Revenue Mix ($m), 2016 29

4.2 Central Venous Catheters Market, India, Segment Contribution (%), 2016 30

4.3 Central Venous Catheters Market, India, Revenue ($m), 2009-2016 31

4.4 Central Venous Catheters Market, India, Revenue ($m), 2016-2023 33

4.5 Central Venous Catheters Market, India, Volume (Units), 2009-2016 35

4.6 Central Venous Catheters Market, India, Volume (Units), 2016-2023 37

4.7 Central Venous Catheters Market, India, Distribution Share by Revenue ($m), 2015-2016 39

4.8 Central Venous Catheters Market, India, Company Share by Revenue ($m), 2016 40

5 Infusion Systems Market, India 42

5.1 Infusion Systems Market, India, Revenue Mix ($m), 2016 42

5.2 Infusion Systems Market, India, Segment Contribution (%), 2016 43

5.3 Infusion Systems Market, India, Revenue ($m), 2009-2016 45

5.4 Infusion Systems Market, India, Revenue ($m), 2016-2023 47

5.4.1 Ambulatory Infusion Pumps Market, India, Revenue ($m), by Segment, 2009-2016 49

5.4.2 Syringe Pumps Market, India, Revenue ($m), by Segment, 2009-2016 51

5.4.3 Ambulatory Infusion Pumps Market, India, Revenue ($m), by Segment, 2016-2023 53

5.4.4 Syringe Pumps Market, India, Revenue ($m), by Segment, 2016-2023 55

5.5 Infusion Systems Market, India, Volume (Units), 2009-2016 57

5.6 Infusion Systems Market, India, Volume (Units), 2016-2023 59

5.6.1 Ambulatory Infusion Pumps Market, India, Volume (Units), by Segment, 2009-2016 61

5.6.2 Syringe Pumps Market, India, Volume (Units), by Segment, 2009-2016 63

5.6.3 Ambulatory Infusion Pumps Market, India, Volume (Units), by Segment, 2016-2023 65

5.6.4 Syringe Pumps Market, India, Volume (Units), by Segment, 2016-2023 67

5.7 Infusion Systems Market, India, Distribution Share by Revenue ($m), 2015-2016 69

5.8 Infusion Systems Market, India, Company Share by Revenue ($m), 2016 70

6 Needle Free Injections Market, India 72

6.1 Needle Free Injections Market, India, Revenue ($m), 2009-2016 72

6.2 Needle Free Injections Market, India, Revenue ($m), 2016-2023 73

6.3 Needle Free Injections Market, India, Volume (Units), 2009-2016 74

6.4 Needle Free Injections Market, India, Volume (Units), 2016-2023 75

6.5 Needle Free Injections Market, India, Distribution Share by Revenue ($m), 2015-2016 76

6.6 Needle Free Injections Market, India, Company Share by Revenue ($m), 2016 77

7 Metered Dose Inhaler Devices Market, India 79

7.1 Metered Dose Inhaler Devices Market, India, Revenue ($m), 2009-2016 79

7.2 Metered Dose Inhaler Devices Market, India, Revenue ($m), 2016-2023 80

7.3 Metered Dose Inhaler Devices Market, India, Volume (Units), 2009-2016 81

7.4 Metered Dose Inhaler Devices Market, India, Volume (Units), 2016-2023 82

7.5 Metered Dose Inhaler Devices Market, India, Distribution Share by Revenue ($m), 2015-2016 83

7.6 Metered Dose Inhaler Devices Market, India, Company Share by Revenue ($m), 2016 84

8 Overview of Key Companies in India, Drug Delivery Devices Market 86

8.1 Teleflex Inc 86

8.1.1 Company Overview 86

8.2 GlaxoSmithKline Plc 86

8.2.1 Company Overview 86

8.3 B. Braun Melsungen AG 86

8.3.1 Company Overview 86

8.4 Baxter International Inc 86

8.4.1 Company Overview 86

8.5 AstraZeneca Plc 87

8.5.1 Company Overview 87

8.6 Boehringer Ingelheim GmbH 87

8.6.1 Company Overview 87

8.7 Fresenius Kabi AG 87

8.7.1 Company Overview 87

8.8 Pfizer Inc 87

8.8.1 Company Overview 87

8.9 Smiths Medical 88

8.9.1 Company Overview 88

8.10 Merck & Co Inc 88

8.10.1 Company Overview 88

8.11 Cipla Ltd 88

8.11.1 Company Overview 88

8.12 Hospira Inc 89

8.12.1 Company Overview 89

8.12 Terumo Corp 89

8.12.1 Company Overview 89

8.19 Becton Dickinson and Co 89

8.19.1 Company Overview 89

8.13 Medtronic Plc 89

8.13.1 Company Overview 89

8.14 Nipro Corp 90

8.14.1 Company Overview 90

9 Drug Delivery Devices Market Pipeline Products 91

10 Financial Deals Landscape 97

10.1 Acquisition 97

10.1.1 Pinfold Overseas Acquires Additional 6.4% Stake in Morepen Labs 97

10.2 Asset Transactions 98

10.2.1 Eurolife Healthcare Acquires Form-Fill-Seal Infusion Business from Baxter 98

10.2.2 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 99

10.3 Equity Offerings 101

10.3.1 Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 101

10.4 Partnerships 102

10.4.1 Sayre Therapeutics Enters into Licensing Agreement with Navidea Biopharma 102

10.4.2 PharmaJet Enters into Agreement with Serum Institute of India 103

10.4.3 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 104

10.4.4 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 105

10.4.5 Eris Lifesciences Enters into Distribution Agreement with India Medtronic 107

10.4.6 Pfizer Terminates its Licensing Agreement with pSivida 108

10.4.7 Bayer Enters into Licensing Agreement with DelSiTech 109

10.4.8 BioCorRx Enters into Licensing Agreement with Therakine 110

11 Recent Developments 111

11.1 Corporate Communications 111

11.1.1 Jul 12, 2017: Sun Pharmaceutical Industries Announces Appointment of Mr. Kalyansundaram Subramanian as the Director 111

11.1.2 Jun 09, 2017: Poly Medicure announces appointment of Chief Operating Officer 111

11.1.3 Apr 12, 2017: Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia 111

11.1.4 Mar 20, 2017: Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer 111

11.1.5 Feb 08, 2017: Cipla Updates Appoints Mr. Mital Sanghvi To Senior Business Finance Role 112

11.1.6 Jan 09, 2017: Cipla appoints Peter Lankau as an Independent Director on its Board 112

11.1.7 Nov 29, 2016: Cipla appoints Ireena Vittal as an Independent Director on its Board 113

11.1.8 Nov 10, 2016: Morepen Labs: Appoints Additional Director 113

11.1.9 Aug 12, 2016: Cipla Names Umang Vohra as MD & Global CEO; Samina Vaziralliis Executive Vice-Chairman 113

11.1.10 Aug 01, 2016: Cipla appoints Kedar Upadhye as Global Chief Financial Officer 114

11.2 Financial Announcements 114

11.2.1 May 26, 2017: Sun Pharma reports Q4 & FY17 results 114

11.2.2 May 25, 2017: Cipla announces Q4 & FY 17 results Continued strong performance across key markets 115

11.2.3 May 12, 2017: Dr. Reddy’s Q4 and FY17 Financial Results 116

11.2.4 Feb 14, 2017: Sun Pharma reports Q3FY17 results 117

11.2.5 Feb 08, 2017: Morepen labs reports yet another growth-filled quarter 119

11.2.6 Feb 04, 2017: Dr. Reddy’s Q3 and 9M FY17 Financial Results 120

11.2.7 Nov 15, 2016: Oncocyte Announces Publication Of Breast Cancer Diagnostic Test Abstract; Poster To Be Presented At The San Antonio Breast Cancer Symposium On December 9, 2016 121

11.2.8 Nov 14, 2016: Medtronic Receives FDA Approval for Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator 122

11.2.9 Nov 14, 2016: With Health Canada approval, Dexcom G5 Mobile CGM System is the First and Only Medical Device in North America for Making Daily Diabetes Decisions Without Painful Fingersticks 123

11.2.10 Nov 11, 2016: CHMP Adopts Positive Opinion to include Self-Administration for RUCONEST 124

11.2.11 Nov 09, 2016: Cipla announces Q2 FY17 results - Improved profitability in base business & Strengthened R&D pipeline 125

11.2.12 Nov 09, 2016: Morepen Labs reports 118 pct jump in net profits for the Q2 of FY 2016-17 126

11.2.13 Oct 25, 2016: Dr. Reddy’s Q2 and H1 FY17 Financial Results 126

11.2.14 Aug 12, 2016: Sun Pharma reports Q1FY17 results 128

11.2.15 Aug 12, 2016: Sun Pharmaceutical Industries announces Unaudited results for the Quarter ended 30 th June, 2016 129

11.2.16 Aug 12, 2016: Cipla announces Q1 FY 17 Results Performance reflects continued momentum in key markets and improvement in base EBITDA margins 130

11.2.17 Aug 01, 2016: Piramal Enterprises Consolidated Results for the First Quarter ended 30 June 2016 131

11.2.18 Jul 26, 2016: Dr. Reddy’s Q1 FY17 Financial Results 132

11.3 Legal And Regulatory 133

11.3.1 Jun 16, 2017: Dr. Reddy's Laboratories: Update on USFDA Audit 133

11.3.2 Jun 14, 2017: Dr. Reddy's Provides Update on API manufacturing plant at Miryalaguda 133

11.3.3 Jun 01, 2017: Successful AAALAC accreditation for Envigo facilities in Hyderabad, India 134

11.3.4 May 29, 2017: Phosphagenic - Mylan Arbitration Update – expert report on quantum of damages claimed filed 134

11.3.5 May 25, 2017: Dr. Reddy's Laboratories Provides Update on Srikakulum Plant 135

11.3.6 Apr 14, 2017: Dr. Reddy’s Provides Update on USFDA Audit 135

11.3.7 Apr 03, 2017: Dr. Reddy's Laboratories Provides Update on USFDA Inspection at Srikakulam plant 135

11.3.8 Mar 14, 2017: Sun Pharma Provides Update on Mohali Facility 135

11.3.9 Mar 14, 2017: Sun Pharmaceutical Industries Provides Update on Mohali Facility 135

11.3.10 Feb 21, 2017: Dr. Reddy's Laboratories Announces US FDA Inspection on Miryalaguda Facility 136

11.3.11 Dec 13, 2016: TUV Certification for the Bengaluru Facility 136

11.3.12 Dec 08, 2016: Sun Pharma Provide Update on USFDA Inspection for Halol facility 136

11.3.13 Sep 30, 2016: Clarification sought from Cipla 136

11.4 Other Significant Developments 137

11.4.1 Feb 08, 2017: Dr. Reddy's Expands Commercial Operations in Europe 137

11.4.2 Jan 10, 2017: Daiichi Sankyo Announces Reorganization of Research & Development System 137

11.5 Product News 137

11.5.1 May 22, 2017: Aptar Pharma to Highlight Drug Delivery Systems Portfolio at FCE Brazil 137

11.6 Strategy And Business Planning 137

11.6.1 Dec 01, 2016: Aptar Pharma Nears Completion Of Elastomer Component Capacity In North America 137

11.6.2 Oct 07, 2016: Leading global pharmaceutical company, Dr. Reddy’s Laboratories now in Colombia 138

11.6.3 Sep 28, 2016: Piramal plans to expand its API development & manufacturing capabilities at Digwal plant 138

12 Appendix 140

12.1 Research Methodology 141

12.1.1 Coverage 141

12.1.2 Secondary Research 141

12.1.3 Primary Research 142

12.1.4 Company Share Analysis 142

12.1.5 Distribution Share Analysis 142

12.1.6 Benchmarking 143

12.2 GlobalData Consulting 143

12.3 Contact Us 144

12.4 Disclaimer 144

List of Tables

1.1 List of Tables

Table 1: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, 2009-2023 13

Table 2: Drug Delivery Devices Market, India ...

1.1 List of Tables

Table 1: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, 2009-2023 13

Table 2: Drug Delivery Devices Market, India, Category Contribution by Revenue ($m), 2016 15

Table 3: Drug Delivery Devices Market, India, Category Comparison by Revenue ($m), 2009-2023 16

Table 4: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 18

Table 5: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 20

Table 6: Drug Delivery Devices Market, India, Volume (Units), 2009-2023 22

Table 7: Drug Delivery Devices Market, India, Volume (Units), Historic, 2009-2016 24

Table 8: Drug Delivery Devices Market, India, Volume (Units), Forecast, 2016-2023 26

Table 9: Drug Delivery Devices Market, India, Company Share by Revenue ($m), USD Constant, 2016 28

Table 10: Central Venous Catheters Market, India, Segment Contribution (%), 2016 30

Table 11: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 32

Table 12: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 34

Table 13: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016 36

Table 14: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023 38

Table 15: Central Venous Catheters Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016 39

Table 16: Central Venous Catheters Market, India, Company Share by Revenue ($m), USD Constant, 2016 41

Table 17: Infusion Systems Market, India, Segment Contribution (%), 2016 44

Table 18: Infusion Systems Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 46

Table 19: Infusion Systems Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 48

Table 20: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 50

Table 21: Syringe Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 52

Table 22: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 54

Table 23: Syringe Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 56

Table 24: Infusion Systems Market, India, Volume (Units), Historic, 2009-2016 58

Table 25: Infusion Systems Market, India, Volume (Units), Forecast, 2016-2023 60

Table 26: Ambulatory Infusion Pumps Market, India, Volume (Units), Historic, 2009-2016 62

Table 27: Syringe Pumps Market, India, Volume (Units), Historic, 2009-2016 64

Table 28: Ambulatory Infusion Pumps Market, India, Volume (Units), Forecast, 2016-2023 66

Table 29: Syringe Pumps Market, India, Volume (Units), Forecast, 2016-2023 68

Table 30: Infusion Systems Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016 69

Table 31: Infusion Systems Market, India, Company Share by Revenue ($m), USD Constant, 2016 71

Table 32: Needle Free Injections Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 72

Table 33: Needle Free Injections Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 73

Table 34: Needle Free Injections Market, India, Volume (Units), Historic, 2009-2016 74

Table 35: Needle Free Injections Market, India, Volume (Units), Forecast, 2016-2023 75

Table 36: Needle Free Injections Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016 76

Table 37: Needle Free Injections Market, India, Company Share by Revenue ($m), USD Constant, 2016 78

Table 38: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 79

Table 39: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 80

Table 40: Metered Dose Inhaler Devices Market, India, Volume (Units), Historic, 2009-2016 81

Table 41: Metered Dose Inhaler Devices Market, India, Volume (Units), Forecast, 2016-2023 82

Table 42: Metered Dose Inhaler Devices Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016 83

Table 43: Metered Dose Inhaler Devices Market, India, Company Share by Revenue ($m), USD Constant, 2016 85

Table 44: Drug Delivery Devices Market Pipeline Products 91

Table 45: Pinfold Overseas Acquires Additional 6.4% Stake in Morepen Labs 97

Table 46: Eurolife Healthcare Acquires Form-Fill-Seal Infusion Business from Baxter 98

Table 47: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 99

Table 48: Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 101

Table 49: Sayre Therapeutics Enters into Licensing Agreement with Navidea Biopharma 102

Table 50: PharmaJet Enters into Agreement with Serum Institute of India 103

Table 51: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 104

Table 52: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 105

Table 53: Eris Lifesciences Enters into Distribution Agreement with India Medtronic 107

Table 54: Pfizer Terminates its Licensing Agreement with pSivida 108

Table 55: Bayer Enters into Licensing Agreement with DelSiTech 109

Table 56: BioCorRx Enters into Licensing Agreement with Therakine 110

List of Figures

1.2 List of Figures

Figure 1: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, 2009-2023 12

Figure 2: Drug Delivery Devices Market, India ...

1.2 List of Figures

Figure 1: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, 2009-2023 12

Figure 2: Drug Delivery Devices Market, India, Revenue Mix ($m), 2016 14

Figure 3: Drug Delivery Devices Market, India, Category Contribution (%), 2016 15

Figure 4: Drug Delivery Devices Market, India, Category Comparison by Revenue ($m), 2009-2023 16

Figure 5: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 17

Figure 6: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 19

Figure 7: Drug Delivery Devices Market, India, Volume (Units), 2009-2023 21

Figure 8: Drug Delivery Devices Market, India, Volume (Units), Historic, 2009-2016 23

Figure 9: Drug Delivery Devices Market, India, Volume (Units), Forecast, 2016-2023 25

Figure 10: Drug Delivery Devices Market, India, Company Share (%) 2016 27

Figure 11: Central Venous Catheters Market, India, Revenue Mix ($m), 2016 29

Figure 12: Central Venous Catheters Market, India, Segment Contribution (%), 2016 30

Figure 13: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 31

Figure 14: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 33

Figure 15: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016 35

Figure 16: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023 37

Figure 17: Central Venous Catheters Market, India, Company Share (%) 2016 40

Figure 18: Infusion Systems Market, India, Revenue Mix ($m), 2016 42

Figure 19: Infusion Systems Market, India, Segment Contribution (%), 2016 43

Figure 20: Infusion Systems Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 45

Figure 21: Infusion Systems Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 47

Figure 22: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 49

Figure 23: Syringe Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 51

Figure 24: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 53

Figure 25: Syringe Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 55

Figure 26: Infusion Systems Market, India, Volume (Units), Historic, 2009-2016 57

Figure 27: Infusion Systems Market, India, Volume (Units), Forecast, 2016-2023 59

Figure 28: Ambulatory Infusion Pumps Market, India, Volume (Units), Historic, 2009-2016 61

Figure 29: Syringe Pumps Market, India, Volume (Units), Historic, 2009-2016 63

Figure 30: Ambulatory Infusion Pumps Market, India, Volume (Units), Forecast, 2016-2023 65

Figure 31: Syringe Pumps Market, India, Volume (Units), Forecast, 2016-2023 67

Figure 32: Infusion Systems Market, India, Company Share (%) 2016 70

Figure 33: Needle Free Injections Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 72

Figure 34: Needle Free Injections Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 73

Figure 35: Needle Free Injections Market, India, Volume (Units), Historic, 2009-2016 74

Figure 36: Needle Free Injections Market, India, Volume (Units), Forecast, 2016-2023 75

Figure 37: Needle Free Injections Market, India, Company Share (%) 2016 77

Figure 38: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 79

Figure 39: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 80

Figure 40: Metered Dose Inhaler Devices Market, India, Volume (Units), Historic, 2009-2016 81

Figure 41: Metered Dose Inhaler Devices Market, India, Volume (Units), Forecast, 2016-2023 82

Figure 42: Metered Dose Inhaler Devices Market, India, Company Share (%) 2016 84

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Saved reports